Mode
Text Size
Log in / Sign up
N/A N=120

Impact of Treatment With ALVEOGYL in Patients With Post-extraction Dry Socket

Dry Socket

Enrolled (actual)
120
Serious AEs
0.0%
Results posted
Feb 2026
Primary outcome: Primary: Pain Using a Visual Analog Scale (VAS : 0-10) — 106; 4 Participants

Study Design & Population

Study type
Observational
Phase
N/A
Interventions
Alveogyl (Device)
Age
Pediatric, Adult, Older Adult · 5+ yrs
Sex
All
Sponsor
Septodont
Primary completion
Jun 2025

Outcome Measures

OutcomeResultp-value
PRIMARY
Pain Using a Visual Analog Scale (VAS : 0-10)
106; 4
SECONDARY
Analgesic Use
63; 47; 20; 90
SECONDARY
Healing of the Alveolar Mucosa
4.0
SECONDARY
Signs of Local Inflammation
19; 91
SECONDARY
Antiseptic Effect
12; 96; 2; 2; 108; 0
SECONDARY
Hemostasis
96; 13; 1; 0; 110; 0
SECONDARY
Complication Rate
0; 110

Summary

Alveogyl (Septodont, Saint-Maur-des-Fossés - France) is a Medical Device used as dressing in case of dry socket. ALVE study is a clinical investigation measuring Alveogyl performance and safety in patients with post-extraction dry socket. The study takes place in India and in France where Alveogyl is already marketed, since 2010 in France and since 2014 in India .

Eligibility Criteria

Inclusion Criteria

  • Male or female patient, adult or child
  • Positive diagnosis of dry socket occurring after the extraction of a permanent tooth (mature or immature)
  • Signed informed consent
  • In France only : Patient affiliated to a Health Insurance Scheme ("sécurité sociale")

Exclusion Criteria

  • Spreading infection in the alveolar socket
  • Placement of Alveogyl done immediately after tooth extraction
  • Multiple post-extraction dry sockets
  • Patient treated with cervico-facial radiotherapy
  • Immunodeficiency related to any diseases or current treatments
  • Psychiatric patient or patient unable to assess his/her pain via the study Pain VAS
  • Patient with history of hypersensitivity to one of the components
  • Patient on post extraction of deciduous teeth
  • Participation in another clinical investigation
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT05536115). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search